Perceptive Advisors LLC has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $4.77 Billion distributed in 112 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Cerevel Therapeutics Holdings, Inc. with a value of $456M, Amicus Therapeutics, Inc. with a value of $331M, Iovance Biotherapeutics, Inc. with a value of $286M, Arcellx, Inc. with a value of $274M, and Nuvalent, Inc. with a value of $209M.

Examining the 13F form we can see an increase of $664M in the current position value, from $4.1B to 4.77B.

Perceptive Advisors LLC is based out at New York, NY

Below you can find more details about Perceptive Advisors LLC portfolio as well as his latest detailed transactions.

Portfolio value $4.77 Billion
Healthcare: $4.76 Billion
ETFs: $4.74 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 112
  • Current Value $4.77 Billion
  • Prior Value $4.1 Billion
  • Filing
  • Period Q1 2024
  • Filing Date May 15, 2024
  • Form Type 13F-HR
  • Activity in Q1 2024
  • New Purchases 25 stocks
  • Additional Purchases 37 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 17 stocks
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.